Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview

This publication has 17 references indexed in Scilit:

• The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
  Annals of Allergy, Asthma & Immunology, 1999
• Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies
  PharmacoEconomics, 1999
• Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthma
  Clinical Therapeutics, 1998
• Prevalence and incidence of asthma and rhinoconjunctivitis in Swedish teenagers
  Allergy, 1998
• Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
  New England Journal of Medicine, 1997
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
  The Lancet, 1994
• The Episode-Free Day as a Composite Measure of Effectiveness
  PharmacoEconomics, 1993
• Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
  Archives of Disease in Childhood, 1993
• Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
  Thorax, 1993
• An Economic Evaluation of Asthma in the United States
  New England Journal of Medicine, 1992